Friday - January 30, 2026

Parkinson’s Disease Psychosis Market Size in the 7MM was ~USD 665 million in 2023 and It is projected to grow by 2034, estimates DelveInsight

DelveInsight’s “Parkinson’s Disease Psychosis Market Insights, Epidemiology, and Market Forecast – 2034″ report delivers an in-depth understanding of Parkinson’s Disease Psychosis, historical and forecasted epidemiology, as well as the Parkinson’s Disease Psychosis market trends in the United States, EU4 (Germany, … Continue reading

Paroxysmal Nocturnal Hemoglobinuria Market Size is projected to grow at a CAGR of 7.1% by 2034, estimates DelveInsight

DelveInsight’s “Paroxysmal Nocturnal Hemoglobinuria Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of the Paroxysmal Nocturnal Hemoglobinuria, historical and forecasted epidemiology and the Paroxysmal Nocturnal Hemoglobinuria market trends in the United States, EU4 (Germany, France, … Continue reading

Hidradenitis Suppurativa Market Size in the 7MM was ~USD ~1,400 Million in 2023 and It is expected to grow by 2034, estimates DelveInsight

DelveInsight’s “Hidradenitis Suppurativa Market Insight, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of hidradenitis suppurativa, historical and forecasted epidemiology, as well as the hidradenitis suppurativa market trends in the United States, EU4 (Germany, France, Italy, and … Continue reading

Cystinosis Market Size in the 7MM is projected to grow at a significant CAGR by 2034, estimates DelveInsight

DelveInsight’s “Cystinosis Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of the Cystinosis, historical and forecasted epidemiology and the Cystinosis market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United … Continue reading

Polymyalgia Rheumatica Treatment Market Size in the 7MM is projected to grow by 2034, estimates DelveInsight

DelveInsight’s “Polymyalgia Rheumatica Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of the Polymyalgia Rheumatica, historical and forecasted epidemiology and the Polymyalgia Rheumatica market trends in the United States, EU4 (Germany, France, Italy, and Spain) … Continue reading

Gorlin Syndrome Clinical Trial Pipeline Shows Potential with Active Contributions from 5+ Key Companies | DelveInsight

DelveInsight’s, “Gorlin Syndrome Pipeline Insight, 2025” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Gorlin Syndrome pipeline landscape. It covers the Gorlin Syndrome pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading

Duchenne Muscular Dystrophy Clinical Trial Pipeline Accelerates as 75+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s “Duchenne Muscular Dystrophy Pipeline Insight 2025” report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Duchenne Muscular Dystrophy pipeline landscape. It covers the Duchenne Muscular Dystrophy pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading

PH-ILD Market Size in the 7MM was ~USD 3 Billion in 2024 and is projected to grow by 2034, estimates DelveInsight

DelveInsight’s “Pulmonary Hypertension associated Interstitial Lung Disease Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of the Pulmonary Hypertension associated Interstitial Lung Disease, historical and forecasted epidemiology and the Pulmonary Hypertension associated Interstitial Lung Disease … Continue reading